ESI-049 Human Pluripotent Stem Cells
Catalog Number: PLX01 003 R01
Cell number per vial: 1 million, 25 million, or 100 million
Pluristyx Ready-to-Differentiate (RTD™) ESI-049 cells are cryopreserved at 1, 25, or 100 million cells per vial with a >80% viable cell recovery when handled and thawed following the instructions for use.
Format: Research Use Only; not for diagnostic or therapeutic purposes
Passage number: <25
NIH Registration Number: 0130
NIH Approval Number: NIHhESC-11-0130
Karyotype: 46, XY
Pluripotency Markers: OCT4 & SSEA-4 (>90%); SSEA-1 (<10%)OCT4 & SSEA-4 (>90%); SSEA-1 (<10%)
ESI-049 hPSCs were derived under current Good Tissue Practice (cGTP) and conform to Global Ethical Standards and Clinical Cell Regulations with complete donor history and testing information. ESI-049 are registered with the National Institutes of Health (NIHhESC-11-0130). Pluristyx is a licensed manufactuer and distributor of ESI-brand of human pluripotent stem cell lines.
Cell Bank Manufacturing
Pluristyx hPSC cell bank vials are tested and confirmed to be free of adventitious agents, including mycoplasma, bacteria, yeast, fungi, and human virus. The cells have been characterized with regards to karyotype, pluripotency, and have been Short Tandem Repeat (STR) fingerprinted to confirm cell line identity.
These cells are for Research Use Only and shall not be developed for diagnostic, therapeutic, or commercial use. Please enquire with Pluristyx for GMP grade vials that may be used for clinical or commercial use.
ESI-049 R&D Vial
Crook, J.M., et al. (2007) The Generation of Six Clinical-Grade Human Embryonic Stem Cell Lines. Cell Stem Cell 1(5): 490-494.
Funk, W.D., et al. (2012) Evaluating the genomic and sequence integrity of human ES cell lines; comparison to normal genomes. Stem Cell Res 8(2): 154-164.